Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice

por Inui, Akimasa, Chung, Yong‐Suk, Sawada, Tetsuji, Kondo, Yasuyuki, Ho, Jenny J. L., Kim, Young‐S., Sowa, Michio
Publicado 1996

Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer

por Nishihara, Tamahiro, Sawada, Tetsuji, Yamamoto, Atsushi, Yamashita, Yoshito, Ho, Jenny J. L., Kim, Young‐Sik, Chung, Kosei Hirakawa‐YS
Publicado 2000

Intratumoral Injection of an Adriamycin Immunoconjugate against Human Pancreatic Cancer Xenografts

por Kondo, Yasuyuki, Chung, Yong‐Suk, Sawada, Tetsuji, Inui, Akimasa, Yamashita, Yoshito, Hirayama, Koji, Nakata, Bunzo, Ho, Jenny J. L., Kim, Young S., Sowa, Michio
Publicado 1995

Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by (111)In‐labeled Chimeric Monoclonal Antibody Nd2

por Sawada, Tetsuji, Nishihara, Tamahiro, Yamamoto, Atsushi, Teraoka, Hitoshi, Yamashita, Yoshito, Okamura, Terue, Ochi, Hironobu, Ho, Jenny J. L., Kim, Young‐Sik, Hirakawa, Kosei
Publicado 1999

Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer

por Chung, Yong‐Suk, Sawada, Tetsuji, Kondo, Yasuyuki, Hirayama, Koji, Inui, Akimasa, Yamashita, Yoshito, Nakata, Bunzo, Okamura, Terue, Ochi, Hironobu, Ho, Jenny J. L., Kim, Young S., Sowa, Michio
Publicado 1997